Literature DB >> 17884225

Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2.

Bernardina T F van der Gun1, Amélie Monami, Sven Laarmann, Tamás Raskó, Krystyna Slaska-Kiss, Elmar Weinhold, Reinhold Wasserkort, Lou F M H de Leij, Marcel H J Ruiters, Antal Kiss, Pamela M J McLaughlin.   

Abstract

Cationic liposomal compounds are widely used to introduce DNA and siRNA into viable cells, but none of these compounds are also capable of introducing proteins. Here we describe the use of a cationic amphiphilic lipid SAINT-2:DOPE for the efficient delivery of proteins into cells (profection). Labeling studies demonstrated equal delivery efficiency for protein as for DNA and siRNA. Moreover, proteins complexed with Saint-2:DOPE were successfully delivered, irrespective of the presence of serum, and the profection efficiency was not influenced by the size or the charge of the protein:cationic liposomal complex. Using beta-galactosidase as a reporter protein, enzymatic activity was detected in up to 98% of the adherent cells, up to 83% of the suspension cells and up to 70% of the primary cells after profection. A delivered antibody was detected in the cytoplasm for up to 7 days after profection. Delivery of the methyltransferase M.SssI resulted in DNA methylation, leading to a decrease in E-cadherin expression. The lipid-mediated multipurpose transport system reported here can introduce proteins into the cell with an equal delivery efficiency as for nucleotides. Delivery is irrespective of the presence of serum, and the protein can exert its function both in the cytoplasm and in the nucleus. Furthermore, DNA methylation by M.SssI delivery as a novel tool for gene silencing has potential applications in basic research and therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884225     DOI: 10.1016/j.jconrel.2007.08.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Effects of employment of distinct strategies to capture antibody on antibody delivery into cultured cells.

Authors:  Kana Kuwahara; Kazuki Harada; Ryohei Yamagoshi; Takenori Yamamoto; Yasuo Shinohara
Journal:  Mol Cell Biochem       Date:  2015-02-20       Impact factor: 3.396

3.  Delivery of antibodies to the cytosol: debunking the myths.

Authors:  Andrea L J Marschall; Congcong Zhang; André Frenzel; Thomas Schirrmann; Michael Hust; Franck Perez; Stefan Dübel
Journal:  MAbs       Date:  2014-05-21       Impact factor: 5.857

4.  cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment.

Authors:  Nirav Khatri; Mohan Rathi; Dipesh Baradia; Ambikanandan Misra
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

5.  Establishment of protein delivery systems targeting podocytes.

Authors:  Wen Chih Chiang; Tessa M Geel; Mehmet M Altintas; Sanja Sever; Marcel H J Ruiters; Jochen Reiser
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

6.  Targeted DNA methylation by a DNA methyltransferase coupled to a triple helix forming oligonucleotide to down-regulate the epithelial cell adhesion molecule.

Authors:  Bernardina T F van der Gun; Maria Maluszynska-Hoffman; Antal Kiss; Alice J Arendzen; Marcel H J Ruiters; Pamela M J McLaughlin; Elmar Weinhold; Marianne G Rots
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

7.  Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.

Authors:  Marcus O W Grimm; Eva G Zinser; Sven Grösgen; Benjamin Hundsdörfer; Tatjana L Rothhaar; Verena K Burg; Lars Kaestner; Thomas A Bayer; Peter Lipp; Ulrike Müller; Heike S Grimm; Tobias Hartmann
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

8.  From Bioengineering to CRISPR/Cas9 - A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting.

Authors:  Albert Jeltsch
Journal:  Front Genet       Date:  2018-01-26       Impact factor: 4.599

9.  Protein transfection study using multicellular tumor spheroids of human hepatoma Huh-7 cells.

Authors:  Takuma Kato; Masakazu Tanaka; Makoto Oba
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine.

Authors:  Yueheng Wu; Lin Jiang; Zixuan Dong; Shaoxian Chen; Xi-Yong Yu; Shunqing Tang
Journal:  Int J Nanomedicine       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.